hDHODH-IN-7

CAS No. 1644156-41-1

hDHODH-IN-7( —— )

Catalog No. M26162 CAS No. 1644156-41-1

DHODH-IN-9 (Compound 10k) is a nitrogen-containing analog and is a human dihydrorotatory dehydrogenase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 264 Get Quote
5MG 404 Get Quote
10MG 593 Get Quote
25MG 888 Get Quote
50MG 1251 Get Quote
100MG 1692 Get Quote
500MG 3402 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    hDHODH-IN-7
  • Note
    Research use only, not for human use.
  • Brief Description
    DHODH-IN-9 (Compound 10k) is a nitrogen-containing analog and is a human dihydrorotatory dehydrogenase inhibitor.
  • Description
    DHODH-IN-9 (Compound 10k) is a nitrogen-containing analog and is a human dihydrorotatory dehydrogenase inhibitor. DHODH-IN-9 and pMIC50 of 7.4 have antiviral effects.(In Vitro):hDHODH-IN-7 is the corresponding pyridazine homologue from 3-chloro-6-cyclopropylpyridazine. There is almost no change, and the antiviral mode of action of the analogs with 5-cyclopyridine reflects the antiviral effect of homologues with 5-ethylpyrimidinyl groups to some extent. hDHODH-IN-7 is a good antiviral agent for such analogs.
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    Apoptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1644156-41-1
  • Formula Weight
    366.4
  • Molecular Formula
    C21H23FN4O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)Oc1nn(c(C)c1Cc1ccccc1F)-c1ncc(cn1)C1CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Moon-Taek Park, et al. Phytosphingosine Induces Apoptotic Cell Death via Caspase 8 Activation and Bax Translocation in Human Cancer Cells. Clin Cancer Res. 2003 Feb;9(2):878-85.
molnova catalog
related products
  • DHODH-IN-11

    DHODH-IN-11 is a leflunomide derivative and weak dihydroorotate dehydrogenase (DHODH) inhibitor with a pKa of 5.03.A compound structurally related to leflunomide was designed, which contained furan ring (compound 14a).

  • CAY10566

    CAY10566 shows excellent cellular activity in blocking the conversion of saturated long-chain fatty acid-CoAs (LCFA-CoAs) to monounsaturated LCFA-CoAs in HepG2 cells (IC50=7.9 nM or 6.8 nM). CAY10566 is a potent, orally bioavailable and selective stearoyl-CoA desaturase1 (SCD1) inhibitor with IC50s of 4.5 and 26 nM in mouse and human enzymatic assays, respectively.

  • Kakkalide

    Kakkalide is a potent lactate dehydrogenase (LDH) inhibitor, it has anti-inflammatory effects.